000 02262nam a2200421 i 4500
001 on1028240804
003 OCoLC
005 20180511125020.0
007 he bmb024bbca
008 180312s2017 dcua bb f000 0 eng c
040 _aGPO
_beng
_erda
_cGPO
_dMvI
042 _apcc
043 _an-us---
050 1 4 _aKF27
_b.E553 2016d
074 _a1019-B-01 (MF)
088 _aSerial no. 114-146 (United States. Congress. House. Committee on Energy and Commerce)
086 0 _aY 4.C 73/8:114-146
099 _aY 4.C 73/8:114-146
110 1 _aUnited States.
_bCongress.
_bHouse.
_bCommittee on Energy and Commerce.
_bSubcommittee on Health,
_eauthor.
245 1 4 _aThe Obama administration's Medicare drug experiment :
_bthe patient and doctor perspective : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, May 17, 2016.
264 1 _aWashington :
_bU.S. Government Publishing Office,
_c2017.
264 2 _aWashington, DC :
_bFor sale by the Superintendent of Documents, U.S. Government Publishing Office
300 _av, 273 pages :
_billustrations ;
_c24 cm
336 _atext
_btxt
_2rdacontent
337 _amicroform
_bh
_2rdamedia
338 _amicrofiche
_bhe
_2rdacarrier
500 _aShipping list no.: 2018-0019-M.
504 _aIncludes bibliographical references.
500 _a"Serial no. 114-146."
500 _aCRDP Program record.
533 _aMicrofiche.
_b[Washington, D.C.] :
_cU.S. Government Printing Office,
_d[2018]
_e2 microfiches : negative.
650 0 _aDrugs
_xPrices
_xGovernment policy
_zUnited States.
650 0 _aPharmaceutical services insurance
_zUnited States.
650 0 _aMedicare
_xClaims administration.
655 7 _aLegislative hearings.
_2lcgft
776 0 8 _iPrint version:
_aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
_tObama administration's Medicare drug experiment.
_dWashington : U.S. Government Publishing Office, 2017
_w(DLC) 2017431820
_w(OCoLC)1004857415
776 0 8 _iOnline version:
_aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
_tObama administration's Medicare drug experiment
_w(OCoLC)1005355835
999 _c271117
_d271117